Cargando…

Predictors and optimal management of tumor necrosis factor antagonist nonresponse in inflammatory bowel disease: A literature review

Tumor necrosis factor-α (TNF-α) antagonists, the first biologics approved for treating patients with inflammatory bowel disease (IBD), are effective for the induction and maintenance of remission and significantly improving prognosis. However, up to one-third of treated patients show primary nonresp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Liang-Fang, Chen, Ping-Run, He, Si-Ke, Duan, Shi-Hao, Zhang, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445007/ https://www.ncbi.nlm.nih.gov/pubmed/37621757 http://dx.doi.org/10.3748/wjg.v29.i29.4481

Ejemplares similares

Serum albumin is the strongest predictor of anti-tumor necrosis factor nonresponse in inflammatory bowel disease in resource-constrained regions lacking therapeutic drug monitoring
por: Kumar, Peeyush, et al.
Publicado: (2023)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
por: Park, Hyo Min, et al.
Publicado: (2013)

Oncostatin M Is a Biomarker of Diagnosis, Worse Disease Prognosis, and Therapeutic Nonresponse in Inflammatory Bowel Disease
por: Verstockt, Sare, et al.
Publicado: (2021)

Gastroenterologists Adherence to Tumor Necrosis Factor Antagonist Combination Therapy in Inflammatory Bowel Disease
por: Abdullah, Israa, et al.
Publicado: (2021)

Nonresponse in household interview surveys
por: Groves, Robert M.
Publicado: (1998)

Treatment goals: response and nonresponse
por: Macher, Jean-Paul, et al.
Publicado: (2004)

Impact of treatment with immunomodulators and tumour necrosis factor antagonists on the incidence of infectious events in patients with inflammatory bowel disease
por: Andersson, Per, et al.
Publicado: (2022)

Comparative Outcomes and Safety of Vedolizumab vs Tumor Necrosis Factor Antagonists for Older Adults With Inflammatory Bowel Diseases
por: Singh, Siddharth, et al.
Publicado: (2022)

Ustekinumab: “Real-world” outcomes and potential predictors of nonresponse in treatment-refractory Crohn’s disease
por: Hoffmann, Peter, et al.
Publicado: (2019)

Treatment of Giardiasis after Nonresponse to Nitroimidazole
por: Meltzer, Eyal, et al.
Publicado: (2014)

Efficacy of Zonisamide in Migraineurs with Nonresponse to Topiramate
por: Chung, Jin-Young, et al.
Publicado: (2014)

Establishing correlation between genetics and nonresponse
por: Raina, SK
Publicado: (2015)

A chronic nonresponsive facial eruption
por: Saikaly, Lara E., et al.
Publicado: (2021)

This CAR won’t start: predicting nonresponse in ALL
por: Webster, Jonathan A., et al.
Publicado: (2023)

A Saudi Gastroenterology Association Position Statement on the Use of Tumor Necrosis Factor-alfa Antagonists for the Treatment of Inflammatory Bowel Disease
por: Mosli, Mahmoud H., et al.
Publicado: (2015)

1728. A Retrospective Analysis of 49 Cases of Histoplasmosis in Inflammatory Bowel Disease Patients on Tumor Necrosis Factor-α Antagonists
por: Harris, Courtney, et al.
Publicado: (2019)

High oncostatin M predicts lack of clinical remission for patients with inflammatory bowel disease on tumor necrosis factor α antagonists
por: Guo, Angela, et al.
Publicado: (2022)

Immunological Predictors of Nonresponse to Directly Acting Antiviral Therapy in Patients With Chronic Hepatitis C and Decompensated Cirrhosis
por: Childs, Kate, et al.
Publicado: (2017)

Recent developments on BMPs and their antagonists in inflammatory bowel diseases
por: Xie, Zhuo, et al.
Publicado: (2023)

The incidence of psoriasis among smokers and/or former smokers inflammatory bowel diseases patients treated with tumor necrosis factor antagonist: A systematic review and meta-analysis
por: Yang, Meiqi, et al.
Publicado: (2021)

Triangulating Differential Nonresponse by Race in a Telephone Survey
por: DeFrank, Jessica T, et al.
Publicado: (2007)

Nonresponse Error in Mail Surveys: Top Ten Problems
por: Daly, Jeanette M., et al.
Publicado: (2011)

Impact of Nonresponse on Medicare Current Beneficiary Survey Estimates
por: Kautter, John, et al.
Publicado: (2006)

Income Disparities and Nonresponse Bias in Surveys of Patient Experience
por: Roberts, Brian W., et al.
Publicado: (2020)

Temozolomide Nonresponsiveness in Aggressive Prolactinomas and Carcinomas: Management and Outcomes
por: Das, Liza, et al.
Publicado: (2021)

Trichloroacetic Acid Cautery for Repigmenting Nonresponsive Vitiligo on Lips
por: Mukhtar, Muhammed
Publicado: (2023)

Investigation of the role of the p38 MAPK α and δ isoforms in nonresponse to tumour necrosis factor blockade in the synovium of rheumatoid arthritis patients
por: Coulthard, LR, et al.
Publicado: (2007)

Anti-tumor necrosis factor therapy in inflammatory bowel disease
por: Ramakrishna, B.S.
Publicado: (2017)

Biosimilars to Antitumor Necrosis Factor Agents in Inflammatory Bowel Disease
por: Al Sulais, Eman, et al.
Publicado: (2020)

Study of tumor necrosis factor receptor in the inflammatory bowel disease
por: Souza, Roberta Figueiroa, et al.
Publicado: (2023)

Predictors of nonresponse and drop-out among children and adolescents receiving TF-CBT: investigation of client-, therapist-, and implementation factors
por: Skar, Ane-Marthe Solheim, et al.
Publicado: (2022)

Dominant nonresponsiveness in the induction of autoimmunity to liver- specific F antigen
Publicado: (1975)

Differentiated Thyroid Cancer: Management of Patients with Radioiodine Nonresponsive Disease
por: Busaidy, Naifa Lamki, et al.
Publicado: (2012)

Aspirin and clopidogrel hyporesponsiveness and nonresponsiveness in patients with coronary artery stenting
por: Sharma, Rakesh K, et al.
Publicado: (2009)

Genetic Prediction of Antidepressant Drug Response and Nonresponse in Korean Patients
por: Lim, Shinn-Won, et al.
Publicado: (2014)

Unit Nonresponse in a Population-Based Study of Prostate Cancer
por: Oral, Evrim, et al.
Publicado: (2016)

On the impact of nonresponse in logistic regression: application to the 45 and Up study
por: Wang, Joanna J. J., et al.
Publicado: (2017)

Tracking Down Nonresponsive Cortical Neurons in Cochlear Implant Stimulation
por: Navntoft, Charlotte Amalie
Publicado: (2017)

Are alternative antibiotics needed for antibiotic-nonresponsive Mycoplasma pneumoniae pneumonia?
por: Yang, Eun-Ae, et al.
Publicado: (2020)

Managing Cardiac Resynchronization Therapy Nonresponse: Conventional and Unconventional Techniques
por: Trohman, Richard G., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_d972fd8hki88l59lof5o5kirbk